The Blood Safety and Quality (Amendment) (EU Exit) Regulations 2019

[F1 3.   In regulation 1, in paragraph (3)—

(a) after the definition of “qualified health professional” insert —

““quality system” means the organisational structure, responsibilities, procedures, processes, and resources for implementing quality management and, for this purpose, “quality management” means the co-ordinated activities to direct and control an organisation with regard to quality at all levels within the blood establishment or hospital blood bank;”;

(b) for the definition of “third country”, substitute—

““third country” means—

(a)

in relation to the import of blood or blood components into Great Britain, a country other than the United Kingdom; and

(b)

in relation to the import of blood or blood components into Northern Ireland, a country other than Northern Ireland or a member State;”.]

Textual Amendments

F1 Reg. 3 substituted (31.12.2020 immediately before IP completion day) by The Blood Safety and Quality (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1304), regs. 1, 3

Commencement Information

I1 Reg. 3 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1